Risk Taking Pauses Ahead of the ECB
Bryter raises $16M for a no-code platform for non-technical people to build enterprise automation apps
Estimating a US price tag of $5K per course, remdesivir is set to make billions for Gilead, says key analyst
Fidelity rolls out enhanced equity ESG ETFs on LSE and Xetra
Snapchat’s ‘dynamic ads’ product for e-commerce retailers rolls out worldwide
Cars: transition from lockdown is a fork in the road – here are two possible outcomes for future travel
Attack of zombie companies: don't let them eat bailouts that are vital to restore the economy
5 Factors Driving Digital Payments Growth
Alibaba Rolls Out Online Business Services As Covid-19 Boosts Digitalization Need
Are fallen angel ETFs preparing to soar?
How pandemics past and present fuel the rise of mega-corporations
Microchip Gains 7% After-Hours On Boosted Guidance; Top Analyst Ups PT
Tesla's Outlook Starting to Clear up With 'Fremont Engines Running,' Says 5-Star Analyst
Herd immunity in Europe – are we close?
The year’s best-performing EM ETF isn’t holding back
Accelerating pharma’s digital IQ as customer engagement evolves
First Trust rolls out cybersecurity and biotechnology ETFs on LSE
Mobile data shows which European countries took lockdown seriously
Investors Could Be Hit By Uneven Stock Markets
Three charts that show where the coronavirus death rate is heading
Can antibody tests tell us who is immune to COVID-19?
Greenback's Slide Continues
Quo vadis, BTPs?
Grizzly On Equity Short Sellers And EU Regulations
Now Will Europe Pull it Together?
The 5G Revolution Could Send These 3 Stocks Higher
FDA approval for Brilinta, EU recommendation for Lynparza
US Dollar Losses are Extended, but Momentum Stalls in the European Morning